0000000000150264

AUTHOR

María Alfonso

showing 3 related works from this author

Peptide-Capped Mesoporous Nanoparticles: Toward a more Efficient Internalization of Alendronate

2020

[EN] Osteoporosis is an illness which appears when the osteoblast/osteoclast activities are unbalanced taking place bone resorption (caused by osteoclasts) in higher extension than bone formation (induced by osteoblasts). Alendronate is one of the most used drugs for osteoporosis treatment despite its scarce bioavailability. Here we present the synthesis and characterization of mesoporous gated nanoparticles (two sets) for the controlled release of alendronate. The first set of nanoparticles (S1) were loaded with sulforhodamine B and capped with a peptide that could be selectively hydrolyzed by cathepsin K enzyme (overexpressed in osteoclasts). The second set (S2) was functionalized with am…

chemistry.chemical_classificationAlendronateChemistrymedia_common.quotation_subjectCathepsin KQUIMICA INORGANICANanoparticlePeptideGeneral ChemistryCombinatorial chemistryEnzymesQUIMICA ORGANICANanoparticlesOsteoporosisMesoporous materialInternalizationmedia_common
researchProduct

A Sensitive Nanosensor for the In Situ Detection of the Cannibal Drug.

2020

[EN] A bio-inspired nanodevice for the selective and sensitive fluorogenic detection of 3,4- methylenedioxypyrovalerone (MDPV), usually known as Cannibal drug, is reported. The sensing nanodevice is based on mesoporous silica nanoparticles (MSNs), loaded with a fluorescent reporter (rhodamine B) and functionalized on their external surface with a dopamine derivative (3), which specifically interacts with the recombinant human dopamine transporter (DAT), capping the pores. In the presence of MDPV, DAT detaches from the MSNs consequently causing rhodamine B release and allowing drug detection. The nanosensor shows a detection limit of 5.2 µM and it is able to detect the MDPV drug both in sali…

Mesoporous silica nanoparticlesDopamineNanosensorNanoparticleBioengineeringDrug detectionMDPVchemistry.chemical_compoundQUIMICA ORGANICANanosensorQUIMICA ANALITICARhodamine Brecombinant human dopamine transporterHumansmesoporous silica nanoparticlesInstrumentationNanodeviceDopamine transporterFluid Flow and Transfer ProcessesDetection limitbiologyProcess Chemistry and TechnologyQUIMICA INORGANICAMesoporous silicaSilicon DioxidechemistryPharmaceutical Preparationsbiology.proteinBiophysicsNanoparticlesRecombinant human dopamine transporter (DAT)nanosensorcannibal drugCannibal drugACS sensors
researchProduct

Nanosensor for Sensitive Detection of the New Psychedelic Drug 25I-NBOMe.

2020

[EN] This work reports the synthesis, characterization, and sensing behavior of a hybrid nanodevice for the detection of the potent abuse drug 25I-NBOMe. The system is based on mesoporous silica nanoparticles, loaded with a fluorescent dye, functionalized with a serotonin derivative and capped with the 5-HT2A receptor antibody. In the presence of 25I-NBOMe the capping antibody is displaced, leading to pore opening and rhodamine B release. This delivery was ascribed to 5-HT2A receptor antibody detachment from the surface due to its stronger coordination with 25I-NBOMe present in the solution. The prepared nanodevice allowed the sensitive (limit of detection of 0.6 mm) and selective recogniti…

SerotoninMesoporous silica nanoparticles25I-NBOMehallucinogenic drugsMescalinesensorsCatalysischemistry.chemical_compoundAgonist 5-HT2A serotonin receptorQUIMICA ORGANICAQUIMICA ANALITICAmedicineRhodamine BHumansmesoporous silica nanoparticlesNanodeviceLysergic acid diethylamideDetection limitSensorsQUIMICA INORGANICAOrganic ChemistryMDMAGeneral ChemistryMesoporous silicaHallucinogenic drugs25I-NBOMeCombinatorial chemistrychemistryDimethoxyphenylethylamine25I-NBOMe agonist 5-HT2A serotonin receptor hallucinogenic drugs mesoporous silica nanoparticles sensorsHallucinogensagonist 5-HT2A serotonin receptormedicine.drug
researchProduct